Event agenda
Tuesday, 23 September 2025
08:30 - 09:30
Registration and coffee
09:30 - 09:50
Welcome by Sylvie Ponchaut & Xavier Hormaechea (BioWin)
09:50 - 10:30
Fireside chat - Belgium in action: How biopharma and health-tech leaders accelerate R&D excellence
- Collaboration
- Health innovation
Join a high-level fireside chat between two of Belgium’s leading health and life sciences CEOs,one from Wallonia, the other from Flanders,as they share how their companies are staying ahead in global R&D.
10:30 - 10:45
Coffee break
10:30 - 16:00
Meetings
- Le Félicien - 1st floor
Meeting duration:20 minute time slots
10:45 - 12:15
1. Ecosystem snapshot - Advanced therapies in Belgium: What we’ve learned, what comes next
- ATMPs
A sharp, data-driven analysis based on expert and BioWin member input: past wins, tough lessons, and critical gaps in Belgium’s advanced therapies ecosystem. This sets the tone for what must change, and what must scale.
2. Interactive Panel - A forward look at Belgium’s advanced therapies ecosystem through lessons learned
- ATMPs
Top minds from industry, policy and research debate real-world success stories to shape the future. What choices will keep Belgium strong in advanced therapies? Join the conversation.
3. Open Q&A - Challenge the vision
- ATMPs
Time to ask your toughest questions, share ideas, and hold the panel accountable. Your voice helps shape the final takeaways.
10:45 - 12:15
1. Strategic snapshot: Wallonia’s nuclear medicine strengths in the Belgian context
- Nuclear medicine
Get a sharp look at Belgium’s nuclear medicine ecosystem, spotlight on Wallonia. Discover the strengths, gaps and recommendations to scale success and shape what’s next.
2. Testimonial - When patient experience meets innovation in nuclear medicine
- Nuclear medicine
A patient and doctor share two views on prostate cancer, living with it and treating it. Together, they show why real-life insight and clinical care must go hand in hand.
3. Interactive panel – Nuclear medicine in action: Innovation through collaboration
- Nuclear medicine
Belgium’s nuclear medicine chain is world-class. This panel dives into how R&D ties boost innovation and access, and what’s next to stay ahead: scale-up, talent, and smart investment.
4. Open Q&A – Beyond the talk
- Nuclear medicine
React. Question. Challenge. What still needs to happen for Belgium to stay ahead?
12:15 - 13:15
Networking lunch
13:30 - 14:15
Keynote - Advancing public health by unlocking Wallonia’s potential in prophylactic vaccine trials
Can Belgium lead in vaccine research again? This talk shares a bold plan to build a national trial network, starting in Wallonia, to boost jobs, strengthen health readiness, and bring Belgium back to the forefront of global vaccine R&D.
Open Q&A – Operationalising Belgium’s vaccine trial ambitions
Time to ask your toughest questions and share ideas. Your voice helps shape the final takeaways.
13:30 - 14:50
1. Setting the scene - Diagnostics in the digital health era: devices, data and integration
- Diagnostics
- Medtech
- Digital health
- IVD
This kickoff session explores how e-health is reshaping diagnostics, from devices to IVDs. Discover how AI, connected care, and digital tools are changing the game for faster, smarter, more personalised patient care.
2. Interactive panel – Diagnostics at a crossroads: From bench to market access
- Diagnostics
- Market access
- Regulatory
Diagnostic innovators face big hurdles in Europe, from red tape to adoption. This panel shares real-world lessons on launching, scaling, and funding diagnostics, with a sharp look at EU vs. U.S. market dynamics.
3. Open Q&A – Beyond the talk
- Diagnostics
- Medtech
- Digital health
It’s your turn. Challenge the panel, question the blockers, and share what it will really take to accelerate diagnostic innovation in Europe.
13:30 - 14:50
1. EIC Accelerator programme: framework, eligibility and opportunities
- EIC Accelerator
- Financing innovation
Get the essentials on the EIC Accelerator: who it’s for, how it works, and how biotech and medtech innovators can tap into funding to scale big ideas.
2. Interactive Panel - funding health innovation: Two startups journeys, two investor perspectives
- Public-private funding
- Financing innovation
Two startups share their funding journeys, from grants to private capital; joined by top EU investors on what drives decisions today. A clear look at how to finance innovation in biotech, medtech, and digital health, and how founders can stand out.
3. Open Q&A - Challenge
- Financing innovation
Time to ask your toughest questions, share ideas, and hold the panel accountable. Your voice helps shape the final takeaways.
14:45 - 15:00
Coffee break
15:00 - 15:45
Keynote - The purpose of innovation
- Health innovation
The session explores how innovation, when rooted in purpose, can address societal challenges and generate sustainable value.
15:45 - 16:15
Europe’s innovation momentum: A strategic outlook for health and competitiveness
European and Belgian authorities will share their vision and ambition for boosting innovation in health and biotech.
16:15 - 16:30
Closing keynote - Looking ahead, together
A forward-looking message, wrap-ups of the day.
16:30 - 18:00
Networking drink
Wednesday, 24 September 2025
10:00 - 14:00
BioWin on Tour
- Advanced therapies
- Nuclear medicine
Want a behind-the-scenes look at where innovation is born and skilfully crafted? On the 24th of September, BioWin on Tour will take you beyond the conference, offering a guided visit through Belgium’s thriving life sciences ecosystem.